Approvals/TGA/SPIKEVAX XBB.1.5 (andusomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial - single-dose

Approved

STANDARD

SPIKEVAX XBB.1.5 (andusomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial - single-dose

Moderna Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 370cb0f5aef07b3d
Product Name: SPIKEVAX XBB.1.5 (andusomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial - single-dose
Artg Id: 418910
Artg Name: SPIKEVAX XBB.1.5 (andusomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial - single-dose
Sponsor: Moderna Australia Pty Ltd
Company Detail Path: /organization/moderna-australia-pty-ltd
Artg Date: 2023-10-10
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/273db03412b0c846dd22d8246b068423.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/efc91854a26e13f5d9220bff9a53ab96.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

370cb0f5aef07b3d

Type

Standard